Rho

Rho expands team in Research Triangle Park

Tuesday, September 26, 2017

Rho, a CRO focused on bringing new products to market through a full range of product development services, plans to hire an additional 40 more team members as part of its growth expansion strategy in 2017.

[Read More]

Engaging patients for a more successful clinical trial

Tuesday, November 15, 2016

Recruitment has always been a key element to a successful clinical trial, and in the past several years the concept of patient engagement—be­yond getting patients in the door—has grown. Historically for rare and orphan disease trials, engagement has helped recruit patients and make sure they are familiar with the treatments involved in the study, which makes them more willing to utilize the treat­ment once it has been approved.

[Read More]

Three Questions: Kevyn Matijevich, Rho

Monday, October 3, 2016

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Kevyn Matijevich, validation specialist at Rho, a full-service CRO that focuses on moving clinical research in a more digital direction.

[Read More]

Rho named Best CRO by Triangle Business Journal

Monday, June 6, 2016

Rho, a full-service CRO focused on bringing new products to market through a full range of product development services, recently announced that the company was named the 2016 Best CRO by Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham and Chapel Hill region of North Carolina, where Rho is headquartered. Rho was also honored with this award in 2015.

[Read More]

FDA expedites drug/biologic development and approval

Thursday, October 15, 2015

The FDA has created four mecha­nisms to expedite development and approval of drugs and biologics that effectively treat serious diseases: Accelerated Approval, Breakthrough Therapy Designation, Priority Review and Fast Track Designation. Under­standing the requirements and ben­efits of each can inform decisions for your development program.

[Read More]

Rho, NIAD partner

Thursday, September 10, 2015

Rho, a privately held CRO based in Chapel Hill, N.C., has been awarded a new cooperative agreement to provide statistical and clinical coordinating services to the Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID). The CRO will provide these services for DAIT’s large clinical research consortia in the areas of asthma and allergic diseases, autoimmune diseases and transplantation.

[Read More]

Rho named a Best CRO with Life Sciences Award

Thursday, May 28, 2015

Rho, a privately-held global CRO, recently was recognized as one of the Best CROs by the Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham, Chapel Hill region of North Carolina, where Rho is headquartered.

[Read More]

Revisiting eClinical Technology Solutions Adoption

Sunday, February 15, 2015

Eight years after the introduction of the first eClinical technologies, many sponsors and CROs remain uncertain about their plans to adopt newer and less common technologies, while use of more established tools continues to grow. [Read More]